Dr. Jim K. Liu, PHARM-D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3150 Fostoria Way, Danville, CA 94526 Phone: 925-277-1800 Fax: 925-277-1839 |
Emily Lai, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3150 Fostoria Way, Danville, CA 94526 Phone: 925-277-1800 |
Mrs. Danielle N Tran, PHARM. D. Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 3496 Camino Tassajara, Danville, CA 94506 Phone: 925-736-0346 Fax: 925-736-0327 |
Julie Mark, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3420 Camino Tassajara, Danville, CA 94506 Phone: 925-736-0262 |
David Lee Jeha Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 611 San Ramon Valley Blvd, Danville, CA 94526 Phone: 925-743-0166 |
News Archive
Streptococcus pneumoniae is a bacterium that can infect the upper respiratory tract and cause pneumonia, as well as infections in other parts of the body such as the bloodstream (bacteremia), lining of the brain and spinal cord (meningitis), bones (osteomyelitis), joints (arthritis), ears (otitis media) and sinuses (sinusitis).
New research presented at this year's Euroanaesthesia congress in Vienna, Austria (1-3 June) shows that mortality in patients who had undergone heart bypass surgery was over 4 times higher in individuals with a high body fat mass, while body mass index (BMI) by itself was not associated with an increase in mortality.
Trilogy, Inc., a behavioral healthcare organization serving people in recovery from serious mental illness, is the recipient of a four-year federal grant from the national Substance Abuse and Mental Health Services Administration (SAMHSA), announced John Mayes, President and CEO of Trilogy, Inc.
Ligand Pharmaceuticals Incorporated today announced that pursuant to an amendment to a March 2006 research agreement with GlaxoSmithKline, GSK has agreed to accelerate the timing of a $500,000 payment to Ligand that would otherwise have been required upon the identification of a new lead chemical series for advancement in its alliance with GSK.
CDEX Inc. announces completion of development-phase testing of a new generation Meth Scannerâ„¢ that embodies cell-phone technology and multi-filter applications. The new generation Scanner will have a cell-phone-interactive readout that increases functionality to provide more options for the law enforcement community in its battle against methamphetamine use. In addition, the technological advancements of multi-filter integration will provide greater sensitivity and a platform for multi-drug applications for the Scanner.
› Verified 2 days ago